Call Options Transactions Made in Q3 2022 in Theravance Biopharma, Inc. (TBPH)
This table provides information about the institutional ownership of Theravance Biopharma, Inc. (TBPH) during Q3 2022. The information is specifically focused on institutions that hold call options of Theravance Biopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
210KNew |
$1.76M - $2.15M
|
210K
$2.07M
|
|
|
Nov 14, 2022
Q3 2022
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
70KNew |
$587K - $715K
|
70K
$690K
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
CALL |
50KNew |
$420K - $511K
|
50K
$493K
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
CALL |
50KNew |
$420K - $511K
|
50K
$493K
|
|
|
Nov 14, 2022
Q3 2022
|
Walleye Trading LLC
Plymouth, MN |
BUY
|
CALL |
37.8KNew |
$317K - $386K
|
37.8K
$372K
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
10.9K+ 12.37% |
$91.5K - $111K
|
99K
$975K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
8K+ 80.0% |
$67.1K - $81.8K
|
18K
$177K
|